Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacokinetics and Pharmacodynamics of Once-Daily Tacrolimus Compared With Twice-Daily Tacrolimus in the Early Stage After Living Donor Liver Transplantation.
Iwasaki M, Yano I, Fukatsu S, Hashi S, Yamamoto Y, Sugimoto M, Fukudo M, Masuda S, Nakagawa S, Yonezawa A, Kaido T, Uemoto S, Matsubara K. Iwasaki M, et al. Among authors: hashi s. Ther Drug Monit. 2018 Dec;40(6):675-681. doi: 10.1097/FTD.0000000000000551. Ther Drug Monit. 2018. PMID: 29965882 Clinical Trial.
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
Hashi S, Masuda S, Kikuchi M, Uesugi M, Yano I, Omura T, Yonezawa A, Fujimoto Y, Ogawa K, Kaido T, Uemoto S, Matsubara K. Hashi S, et al. Transplant Proc. 2014 Apr;46(3):758-60. doi: 10.1016/j.transproceed.2013.11.060. Transplant Proc. 2014. PMID: 24767342
Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation.
Yano I, Masuda S, Egawa H, Sugimoto M, Fukudo M, Yoshida Y, Hashi S, Yoshizawa A, Ogura Y, Ogawa K, Mori A, Kaido T, Uemoto S, Inui K. Yano I, et al. Among authors: hashi s. Eur J Clin Pharmacol. 2012 Mar;68(3):259-66. doi: 10.1007/s00228-011-1129-x. Epub 2011 Oct 4. Eur J Clin Pharmacol. 2012. PMID: 21969228 Free article. Clinical Trial.
Successful telaprevir treatment in combination of cyclosporine against recurrence of hepatitis C in the Japanese liver transplant patients.
Kikuchi M, Okuda Y, Ueda Y, Nishioka Y, Uesugi M, Hashimoto E, Takahashi T, Kawai T, Hashi S, Shinke H, Omura T, Yonezawa A, Ito T, Fujimoto Y, Kaido T, Chiba T, Uemoto S, Matsubara K, Masuda S. Kikuchi M, et al. Among authors: hashi s. Biol Pharm Bull. 2014;37(3):417-23. doi: 10.1248/bpb.b13-00769. Epub 2013 Dec 26. Biol Pharm Bull. 2014. PMID: 24369269 Free article.
Association between CYP3A5 genotypes in graft liver and increase in tacrolimus biotransformation from steroid treatment in living-donor liver transplant patients.
Hosohata K, Uesugi M, Hashi S, Hosokawa M, Inui K, Matsubara K, Ogawa K, Fujimoto Y, Kaido T, Uemoto S, Masuda S. Hosohata K, et al. Among authors: hashi s. Drug Metab Pharmacokinet. 2014;29(1):83-9. doi: 10.2133/dmpk.dmpk-13-rg-060. Epub 2013 Aug 13. Drug Metab Pharmacokinet. 2014. PMID: 23955548 Free article.
19 results